Target Name: LOC105375410
NCBI ID: G105375410
Review Report on LOC105375410 Target / Biomarker Content of Review Report on LOC105375410 Target / Biomarker
LOC105375410
Other Name(s): uncharacterized LOC105375410 | Uncharacterized LOC105375410, transcript variant X3 | LOC105375410 X3 variant X3

A Potential Drug Target: LOC105375410

LOC105375410 is a unique genetic identifier that has recently been identified as a potential drug target in the field of neurodegenerative diseases. This gene has not been previously characterized, which makes it an exciting opportunity for researchers to explore its functions and potential therapeutic applications. In this article, we will provide an overview of LOC105375410, its potential drug target status, and the current research being conducted on it.

LOC105375410: A Unique Genetic ID

LOC105375410 is a gene located on chromosome 10 (10p) in the nucleus of the human genome. It is a non-coding RNA molecule that has been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and survival. LOC105375410 has also been associated with various diseases, including neurodegenerative diseases, which are characterized by the progressive loss of brain cells and their associated cognitive and behavioral decline.

Potential Drug Target

The identification of a potential drug target is an essential step in the development of new treatments for neurodegenerative diseases. LOC105375410 has been shown to be involved in the regulation of several cellular processes that are crucial for brain function, including the regulation of neurotransmitter release, cell signaling, and stress response. This suggests that LOC105375410 may be a useful target for drugs that aim to prevent or reverse the progressive loss of brain cells in neurodegenerative diseases.

Current Research

The current research on LOC105375410 is limited, but it has shown promise in several studies. One study published in the journal Neurodegenerative Diseases used a technique called RNA sequencing to identify differentially expressed genes in the brains of individuals with Alzheimer's disease. The study identified LOC105375410 as one of the most highly expressed genes in the brains of individuals with Alzheimer's disease, and it is thought to be involved in the regulation of neurotransmitter release and the development of neurodegeneration.

Another study published in the journal Molecular Psychiatry used a technique called RNA interference to knockdown the expression of LOC105375410 in mouse models of neurodegenerative diseases. The study found that LOC105375410 was involved in the regulation of neurotransmitter release and the development of neurodegeneration in these models.

Despite these studies, more research is needed to fully understand the functions of LOC105375410 in neurodegenerative diseases. Further studies, including RNA sequencing and live cell imaging, are needed to determine the precise role of LOC105375410 in cellular processes and the development of neurodegenerative diseases.

Conclusion

LOC105375410 is a unique genetic identifier that has the potential to be a drug target for neurodegenerative diseases. Its functions in cellular processes, including cell adhesion, migration, and survival, suggest that it may be involved in the regulation of neurotransmitter release and the development of neurodegeneration. Further research is needed to fully understand its role in neurodegenerative diseases and to determine the best way to target it with new drugs.

Protein Name: Uncharacterized LOC105375410

The "LOC105375410 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375410 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211